These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38040684)

  • 41. Potent inhibitory ligands of the GRB2 SH2 domain from recombinant peptide libraries.
    Hart CP; Martin JE; Reed MA; Keval AA; Pustelnik MJ; Northrop JP; Patel DV; Grove JR
    Cell Signal; 1999 Jun; 11(6):453-64. PubMed ID: 10400318
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure, dynamics, and binding thermodynamics of the v-Src SH2 domain: implications for drug design.
    Taylor JD; Ababou A; Fawaz RR; Hobbs CJ; Williams MA; Ladbury JE
    Proteins; 2008 Dec; 73(4):929-40. PubMed ID: 18536014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of phosphorylated FcepsilonRIgamma immunoglobulin receptor tyrosine activation motif-based peptides with dual and single SH2 domains of p72syk. Assessment of binding parameters and real time binding kinetics.
    Chen T; Repetto B; Chizzonite R; Pullar C; Burghardt C; Dharm E; Zhao Z; Carroll R; Nunes P; Basu M; Danho W; Visnick M; Kochan J; Waugh D; Gilfillan AM
    J Biol Chem; 1996 Oct; 271(41):25308-15. PubMed ID: 8810294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential recognition of syk-binding sites by each of the two phosphotyrosine-binding pockets of the Vav SH2 domain.
    Chen CH; Piraner D; Gorenstein NM; Geahlen RL; Beth Post C
    Biopolymers; 2013 Nov; 99(11):897-907. PubMed ID: 23955592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains.
    Myers MG; White MF
    Diabetes; 1993 May; 42(5):643-50. PubMed ID: 8387037
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SH2 domains: role, structure and implications for molecular medicine.
    Waksman G; Kumaran S; Lubman O
    Expert Rev Mol Med; 2004 Jan; 6(3):1-18. PubMed ID: 14987415
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Presence of SH2 domains of phospholipase C gamma 1 enhances substrate phosphorylation by increasing the affinity toward the epidermal growth factor receptor.
    Rotin D; Honegger AM; Margolis BL; Ullrich A; Schlessinger J
    J Biol Chem; 1992 May; 267(14):9678-83. PubMed ID: 1315766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
    Mayer BJ; Baltimore D
    Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural basis for dimerization of the Grb10 Src homology 2 domain. Implications for ligand specificity.
    Stein EG; Ghirlando R; Hubbard SR
    J Biol Chem; 2003 Apr; 278(15):13257-64. PubMed ID: 12551896
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.
    Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H
    Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A phosphorylation-dependent gating mechanism controls the SH2 domain interactions of the Shc adaptor protein.
    George R; Schuller AC; Harris R; Ladbury JE
    J Mol Biol; 2008 Mar; 377(3):740-7. PubMed ID: 18279888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical and NMR characterization of the interactions of Vav2-SH2 domain with lipids and the EphA2 juxtamembrane region on membrane.
    Ge L; Wu B; Zhang Y; Wang J; Zhao H; Wang J
    Biochem J; 2020 Oct; 477(19):3791-3801. PubMed ID: 32897354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple SH2-mediated interactions in v-src-transformed cells.
    Koch CA; Moran MF; Anderson D; Liu XQ; Mbamalu G; Pawson T
    Mol Cell Biol; 1992 Mar; 12(3):1366-74. PubMed ID: 1545818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The SH2 domain: versatile signaling module and pharmaceutical target.
    Machida K; Mayer BJ
    Biochim Biophys Acta; 2005 Feb; 1747(1):1-25. PubMed ID: 15680235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1.
    Mohammadi M; Honegger AM; Rotin D; Fischer R; Bellot F; Li W; Dionne CA; Jaye M; Rubinstein M; Schlessinger J
    Mol Cell Biol; 1991 Oct; 11(10):5068-78. PubMed ID: 1656221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Demonstration of Binding Induced Structural Plasticity in a SH2 Domain.
    Visconti L; Toto A; Jarvis JA; Troilo F; Malagrinò F; De Simone A; Gianni S
    Front Mol Biosci; 2020; 7():89. PubMed ID: 32528972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain.
    Sasaki A; Yasukawa H; Suzuki A; Kamizono S; Syoda T; Kinjyo I; Sasaki M; Johnston JA; Yoshimura A
    Genes Cells; 1999 Jun; 4(6):339-51. PubMed ID: 10421843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains.
    Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA
    Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combining biophysical methods to analyze the disulfide bond in SH2 domain of C-terminal Src kinase.
    Liu D; Cowburn D
    Biophys Rep; 2016; 2(1):33-43. PubMed ID: 27819029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.